Suchergebnisse - "Rosoph, L"

PubPharm (11)

1

Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate-to-severe chronic plaque psoriasis

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2020

von Poulin, Y. | Ramon, M. | Rosoph, L. | +5

2

Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate‐to‐severe chronic plaque psoriasis

enthalten in: Journal of the European Academy of Dermatology and Venereology | 2020

von Poulin, Y. | Ramon, M. | Rosoph, L. | +5

3

Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis : results from a double-blind, placebo-controlled, randomized study

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2018

von Bissonnette, R. | Haydey, R. | Rosoph, L. | +11

4

Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris : a transatlantic, randomized, double-blind, controlled study in 1670 patients

enthalten in: The British journal of dermatology | 2009

von Gollnick, H. | Draelos, Z. | Glenn, M. | +64

5

Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients

enthalten in: The British journal of dermatology | 2009

von Gollnick, H. | Draelos, Z. | Glenn, M. | +6

6

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis : 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

enthalten in: Lancet (London, England) | 2008

von Leonardi, C. | Kimball, A. | Papp, K. | +55

ErratumIn: Lancet. 2008 May 31;371(9627):1838

7

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis : 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

enthalten in: Lancet (London, England) | 2008

von Papp, K. | Langley, R. | Lebwohl, M. | +81

CommentIn: Lancet. 2008 May 17;371(9625):1639-40. - PMID 18486724

8

Efficacy of ISA247 in plaque psoriasis : a randomised, multicentre, double-blind, placebo-controlled phase III study

enthalten in: Lancet (London, England) | 2008

von Papp, K. | Bissonnette, R. | Rosoph, L. | +6

CommentIn: Lancet. 2008 Apr 19;371(9621):1311-2. - PMID 18424307

9

Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study

enthalten in: The lancet | 2008

von Papp, K. | Bissonnette, R. | Rosoph, L. | +6

10

Dermatology Secrets in Color

enthalten in: Journal of cutaneous medicine and surgery | 2002

von Rosoph, L.